Partnering to achieve a
We’re all in this together
DxTerity and clinical researchers share a common goal: to advance the understanding, treatment and management of immune-mediated disease. To that end, DxTerity is committed to providing researchers with integrated patient-centric services to drive deep discovery and rapid product commercialization.
Comprehensive Suite of Services
DxTerity’s diagnostic development process provides a full suite of services to advance the next generation of low-cost, high-volume molecular diagnostics through the commercialization process.
Direct-to-Patient Clinical Research
Precision Genomic Testing
IVD Product Co-development
Direct patient recruitment and from-home sample collection for large studies
Low-cost genomic solutions for molecular diagnostic discovery and clinical development
Co-development services for IVD products under US FDA Design Control and CE-IVD requirements
Novel Technology for Immune-Mediated Diseases
DxTerity’s proprietary technology stabilizes RNA at ambient temperature while eliminating complex sample preparation requirements through direct-from-sample processing. This unique technology supports genomic research and monitoring in immune-mediated disease applications both when the immune system creates an over-reaction as well as an under-reaction to internal and external factors.